A novel RT-PCR-based protein activity truncation assay for direct assessment of deoxycytidine kinase in small numbers of purified leukemic cells

Leukemia

Volumn 14, Issue 9, 2000, Pages 1678-1684

  Veuger, M J T ^a   Honders, M W ^a   Landegent, J E ^a   Willemze, R ^a   Barge, R M Y ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Acute myeloid leukemia (AML); Cytarabine (AraC); DCK activity; Deoxycytidine kinase (dCK); Drug resistance; RT PCR

Indexed keywords

2 CHLORO 2',3' DIDEOXYADENOSINE; 5 AZA 2' DEOXYCYTIDINE; ADENOSINE TRIPHOSPHATE; CYTARABINE; DEOXYCYTIDINE KINASE; RNA POLYMERASE; URIDINE TRIPHOSPHATE;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; LEUKEMIA CELL; MOLECULAR WEIGHT; NONHUMAN; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; TRANSLATION REGULATION;

EID: 0033832596     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401880     Document Type: Article

References (27)

1. A randomized phase II study on the effects of 5-aza-2'-deoxycytidine combined with either amsacrine or idarubicin in patients with relapsed acute leukemia: An EORTC Leukemia Cooperative Group phase II study (06893)
2. What is the best induction regimen for acute myelogenous leukemia?
3. Treatment of resistant disease
4. Mammalian deoxynucleoside kinase. I. Deoxycytidine kinase: Purification, properties, and kinetic studies with cytosine arabinoside
5. The effects of cytosine arabinoside oil RNA-primed DNA synthesis by DNA polymerase alpha-primase
6. Lethality of human myeloblasts correlates with the incorporation of arab-inofuranosylcytosine into DNA
7. Resistance to 1-beta-D-arabinofuranosylcytosine in human T-lymphoblasts mediated by mutations within the deoxycytidine kinase gene
8. Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D-arabinofuranosylcytosine
9. Development of resistance to 1-beta-D-arabinofuranosylcytosine after high-dose treatment in childhood lymphoblastic leukemia: Analysis of resistance mechanism in established cell lines
10. Decreased resistance to gemcitabine (2',2'-difluorodeoxycitidine) of cytosine arabinoside-resistant myeloblastic murine and rat leukemia cell lines: Rrole of altered activity and substrate specificity of deoxycytidine kinase
11. Development and molecular characterization of a 2',2'-difluoro-deoxycytidine-resistant variant of the human ovarian carcinoma cell line A2780
12. Common resistance mechanisms to deoxynucleoside analogues in variants of the human erythroleukaemic line K562
13. In vitro-induced resistance to the deoxycytidine analogues cytarabine (AraC) and 5-aza-2'-deoxycytidine (DAC) in a rat model for acute myeloid leukemia is mediated by mutations in the deoxycytidine kinase (dck) gene
14. De novo induced mutations in the deoxycytidine kinase (dck) gene in rat leukemic clonal cell lines confer resistance to cytarabine (AraC) and 5-axa-2-deoxycytidine (DAC)
15. Transfection of wild-type deoxycytidine kinase (dck) cDNA into an AraC- and DAC-resistant rat leukemic cell line of clonal origin fully restores drug sensitivity
16. Differences in kinetic properties of pure recombinant human and mouse deoxycytidine kinase
17. Phosphorylation of 2-chlorodeoxyadenosine (CdA) in extracts of peripheral blood mononuclear cells of leukaemic patients
18. 1-beta-D-arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of in vivo murine tumor cell response
19. Use of T7 RNA polymerase to direct expression of cloned genes
20. In vivo development of cytosine arabinoside resistance in the BN acute myelocytic leukemia
21. In vivo studies on high-dose 1-beta-D-arabinofuranosylcytosine (HDara-C) and 1-beta-D-arabinofuranosyluracil (ara-U) with respect to pharmacokinetics, cell kinetics, and cytotoxicity in a rat myelocytic leukemia model
22. Cytokine production by the bladder carcinoma cell line 5637: Rapid analysis of mRNA expression levels using a cDNA-PCR procedure
23. Human deoxycytidine kinase. Purification and characterization of the cytoplasmic and mitochondrial isozymes derived from blast cells of acute myelocytic leukemia patients
24. Structural analysis of the deoxycytidine kinase gene in patients with acute myeloid leukemia and resistance to cytosine arabinoside
25. Drug sensitivity test for patients with accute leukemia on high-dose ara-C therapy
26. Selective assays for thymidine kinase 1 and 2 and deoxycytidine kinase and their activities in extracts from human cells and tissues
27. The effects of high salt concentrations on the regulation of the substrate specificity of human recombinant deoxycytidine kinase